A Phase I, Single Centre, Open Study to Assess the Pharmacokinetics of Oral AZD6140 After Single Dose in Healthy Japanese Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 12 Jul 2012
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes; Embolism and thrombosis
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 01 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 08 May 2012 New trial record